Abstract
Chemotherapy-induced thrombocytopenia (CIT, platelet [PLT] count ≤ 100,000/μL after chemotherapy) is a common side effect with an incidence ranging from 16.5% to 21.8% in the global population, but higher than 30% in the patients treated with platinum- or gemcitabine-based regimens. Its treatment is an unmet need and several agents have been studied with unsatisfactory results. Corticosteroids (CSs) are commonly used, even if low evidence is available. The present study aims to observe whether CSs have a positive impact on the outcome of CIT.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call